Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SKY: Bilastine and montelukast in seasonal allergic rhinoconjunctivitis and asthma
2015-004806-40Phase 4Completed
- Sponsor
- Menarini Group
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of bilastine and montelukast in seasonal allergic rhinitis (SAR) and asthma (3 arms), sponsored by Menarini Group. Primary endpoint: Total Symptoms Score (TSS) change at 4 weeks. Started Feb 2016; status: completed.
02
Drugs
bilastinemontelukast
03
Conditions
seasonal allergic rhinitis (SAR)asthma
Beyond the preview
Go deeper on 2015-004806-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004806-40.